Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) related to its merger with Korsana Biosciences, Inc. Upon the closing of the proposed transaction, Cyclerion shareholders are expected to own approximately 1.5% of the combined company.
Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) related to its merger with Korsana Biosciences, Inc. Upon the closing of the proposed transaction, Cyclerion shareholders are expected to own approximately 1.5% of the combined company.